🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Trial investigates the benefits and harms of Levodopa /Carbidopa 100/25mg c...
Status
Active Not Recruiting
Location
Kantonsspital Aarau, Neurozentrum
Start Date
2019-06-14
Trial ID
NCT03735901
Treatments Being Tested
ZM-H1505R is an investigational drug developed by Shanghai Zhimeng Biopharm...
Status
Completed
Location
Frontage Clinical Services
Start Date
2020-02-17
Trial ID
NCT04220801
Treatments Being Tested
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999
International, multicentre, prospective, randomized, double-blind, placebo-...
Status
Completed
Location
IMUNOGLUKAN CZ, s.r.o.
Start Date
2023-09-25
Trial ID
NCT06974747
Treatments Being Tested
This research study is designed to evaluate the safety, tolerability, and e...
Status
Terminated
Location
UCLA Stroke Network
Start Date
2004-09
Trial ID
NCT00272909
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
In this double-blinded randomized clinical trial study, investigators asses...
Status
Completed
Location
CHU de Québec, radio-oncology departement
Start Date
2006-12
Trial ID
NCT01839721
This randomized dose-ranging study will evaluate the safety, tolerability, ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01520116
The purpose of this study is to evaluate the safety, efficacy, and tolerabi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT00741884
This is a multicenter, randomized, double-blind, placebo-controlled, dose-E...
Status
Completed
Location
Allife Medicine （Beijing） Limitied
Start Date
2023-08-24
Trial ID
NCT05993884